Heterogeneous PSMA expression on circulating tumor cells - a potential basis for stratification and monitoring of PSMA-directed therapies in prostate cancer

The prostate specific membrane antigen (PSMA) is the only clinically validated marker for therapeutic decisions in prostate cancer (PC). Characterization of circulating tumor cells (CTCs) obtained from the peripheral blood of PC patients might provide an alternative to tissue biopsies called “liquid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncotarget
Hauptverfasser: Gorges, Tobias M., Riethdorf, Sabine, von Ahsen, Oliver, Nastały, Paulina, Röck, Katharina, Boede, Marcel, Peine, Sven, Kuske, Andra, Schmid, Elke, Kneip, Christoph, König, Frank, Rudolph, Marion, Pantel, Klaus
Format: Artigo
Sprache:Inglês
Veröffentlicht: Impact Journals LLC 2016
Schlagworte:
Research Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5085200/
https://ncbi.nlm.nih.gov/pubmed/27145459
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9004
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge